The Parkinson's disease (PD) drugs market size is expected to grow by $1.57B from 2019 to 2024 at a CAGR of 6% as per the latest market report by Technavio. 37% of the market's growth will originate from Europe during the forecast period. Germany, Italy, the UK, and Spain are the key markets for Parkinson's disease (PD) drugs in Europe. Market growth in this region will be faster than the market's growth in the Asian and North American regions. The strong prevalence of PD and the easy availability of multiple approved drugs will facilitate the Parkinson's disease (PD) drug market growth in Europe over the forecast period.
The Parkinsons' disease (PD) drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. The Parkinson's disease (PD) drugs market report also offers information on several market vendors, including AbbVie Inc., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Eisai Co. Ltd., GlaxoSmithKline Plc, Kyowa Kirin Co. Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., and UCB SA among others.